1. Home
  2. LMT vs SNY Comparison

LMT vs SNY Comparison

Compare LMT & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lockheed Martin Corporation

LMT

Lockheed Martin Corporation

HOLD

Current Price

$456.25

Market Cap

105.1B

Sector

Industrials

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$49.87

Market Cap

119.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMT
SNY
Founded
1912
1994
Country
United States
France
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.1B
119.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LMT
SNY
Price
$456.25
$49.87
Analyst Decision
Buy
Buy
Analyst Count
14
4
Target Price
$518.79
$61.50
AVG Volume (30 Days)
1.3M
2.2M
Earning Date
10-21-2025
10-24-2025
Dividend Yield
3.01%
3.21%
EPS Growth
N/A
105.93
EPS
17.88
8.67
Revenue
$73,349,000,000.00
$53,890,648,839.00
Revenue This Year
$5.97
$2.37
Revenue Next Year
$4.24
$6.51
P/E Ratio
$25.60
$11.32
Revenue Growth
2.88
N/A
52 Week Low
$410.11
$44.62
52 Week High
$529.48
$60.12

Technical Indicators

Market Signals
Indicator
LMT
SNY
Relative Strength Index (RSI) 38.81 48.29
Support Level $448.48 $49.14
Resistance Level $457.26 $50.61
Average True Range (ATR) 8.09 0.76
MACD -0.65 -0.18
Stochastic Oscillator 21.28 28.73

Price Performance

Historical Comparison
LMT
SNY

About LMT Lockheed Martin Corporation

Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Aeronautics is Lockheed's largest segment, which derives upward of two-thirds of its revenue from the F-35. Lockheed's remaining segments are rotary and mission systems, mainly encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: